Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
T&R Biofab CoXKRX:246710 -0.68%57 Current Ratio is 0.33 as of Jun. 2026, which is 96% below its 10-year median of 7.75. GuruFocus rates XKRX:246710 with a GF Score™ of 57/100 and a GF Value™ of ₩19,469.96 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 851 Medical Devices & Instruments companies, T&R Biofab Co ranks worse than 96.12% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. T&R Biofab Co's current ratio for the quarter that ended in Jun. 2026 was 0.33.
T&R Biofab Co has a current ratio of 0.33. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If T&R Biofab Co has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for T&R Biofab Co's Current Ratio or its related term are showing as below:
XKRX:246710'
s Current Ratio Range Over the Past 10 Years
Min: 0.33 Med: 7.75 Max: 99.66
Current: 0.33
During the past 12 years, T&R Biofab Co's highest Current Ratio was 99.66. The lowest was 0.33. And the median was 7.75.
XKRX:246710's Current Ratio is ranked worse than 96.12% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs XKRX:246710: 0.33
T&R Biofab Co (XKRX:246710) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
T&R Biofab Co Current Ratio Related Terms
T&R Biofab Co Current Ratio Historical Data
* Premium members only.
The historical data trend for T&R Biofab Co's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:246710 vs ABT, SYK, MDT: Current Ratio Comparison
For the Medical Devices subindustry, T&R Biofab Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T&R Biofab Co Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, T&R Biofab Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where T&R Biofab Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T&R Biofab Co (XKRX:246710) has a Current Ratio of 0.33 as of Jun. 2026. This is 96% below median its historical median of 7.75. Over the past decade, T&R Biofab Co's Current Ratio has ranged from 0.33 to 99.66. According to the industry distribution chart, T&R Biofab Co ranks #818 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 96.1%.
Is T&R Biofab Co's Current Ratio too high?
T&R Biofab Co's current Current Ratio of 0.33 is 96% below median its 10-year median of 7.75. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 99.66. The Medical Devices & Instruments industry median Current Ratio is 2.43. T&R Biofab Co's value of 0.33 is 86.4% below this industry median. Based on the distribution chart, T&R Biofab Co ranks #818 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, T&R Biofab Co has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does T&R Biofab Co's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, T&R Biofab Co ranks #818 out of 851 companies for Current Ratio. This places T&R Biofab Co in the lower half of its industry. The industry median Current Ratio is 2.43. T&R Biofab Co's value of 0.33 is 86.4% below this benchmark. Historically, T&R Biofab Co's own Current Ratio has ranged from 0.33 to 99.66 over the past decade. While the company's 10-year median is 7.75 vs. the industry median of 2.43, T&R Biofab Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.43, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. T&R Biofab Co's current Current Ratio of 0.33 is 86.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. T&R Biofab Co's current Current Ratio is 0.33, which is 96% below median its own 10-year median of 7.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T&R Biofab Co stock overvalued right now?
Based on GuruFocus' analysis, T&R Biofab Co (XKRX:246710) is currently considered Possible Value Trap. The stock's GF Value™ is ₩19,469.96, compared to a current price of ₩2,200.00 — trading 88.7% below its estimated fair value. The current Current Ratio is 0.33, which is 96% below median its 10-year median of 7.75 and 86.4% below the Medical Devices & Instruments industry median of 2.43. T&R Biofab Co's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For T&R Biofab Co (XKRX:246710), the current Current Ratio is 0.33 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is T&R Biofab Co (XKRX:246710) Overvalued in 2026?
Based on GuruFocus' analysis, T&R Biofab Co stock appears to be undervalued.
The current stock price of ₩2,200.00 is trading 88.7% below its estimated GF Value™ of ₩19,469.96.
GuruFocus considers T&R Biofab Co to be Possible Value Trap.
Key valuation signals for XKRX:246710:
Current Ratio: 0.33 (96% below median its 10-year median of 7.75)
GF Value™: ₩19,469.96 vs. price of ₩2,200.00 (88.7% below fair value)
Industry Position: 86.4% below the Medical Devices & Instruments median (#818 of 851)
No single metric tells the full story. See the XKRX:246710 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.
57GF Score
Get the complete analysis for XKRX:246710
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:246710 has been successfully added to your 
